Works matching AU Deeken, John F.


Results: 16
    1
    2
    3
    4

    Quantitative proteomic analysis of HER2 protein expression in PDAC tumors.

    Published in:
    Clinical Proteomics, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12014-024-09476-7
    By:
    • Randall, Jamie;
    • Hunt, Allison L.;
    • Nutcharoen, Aratara;
    • Johnston, Laura;
    • Chouraichi, Safae;
    • Wang, Hongkun;
    • Winer, Arthur;
    • Wadlow, Raymond;
    • Huynh, Jasmine;
    • Davis, Justin;
    • Corgiat, Brian;
    • Bateman, Nicholas W.;
    • Deeken, John F.;
    • Petricoin, Emanuel F.;
    • Conrads, Thomas P.;
    • Cannon, Timothy L.
    Publication type:
    Article
    5
    6
    7
    8
    9

    A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 8, p. 1194, doi. 10.1002/cncr.28554
    By:
    • Rudek, Michelle A.;
    • Moore, Page C.;
    • Mitsuyasu, Ronald T.;
    • Dezube, Bruce J.;
    • Aboulafia, David;
    • Gerecitano, John;
    • Sullivan, Ryan;
    • Cianfrocca, Mary E.;
    • Henry, David H.;
    • Ratner, Lee;
    • Haigentz, Missak;
    • Dowlati, Afshin;
    • Little, Richard F.;
    • Ivy, Susan Percy;
    • Deeken, John F.
    Publication type:
    Article
    10

    A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 21, p. 5403, doi. 10.1002/cncr.27526
    By:
    • Pishvaian, Michael J.;
    • Marshall, John L.;
    • Wagner, Andrew J.;
    • Hwang, Jimmy J.;
    • Malik, Shakun;
    • Cotarla, Ion;
    • Deeken, John F.;
    • He, A. Ruth;
    • Daniel, Hirut;
    • Halim, Abdel-Baset;
    • Zahir, Hamim;
    • Copigneaux, Catherine;
    • Liu, Kejian;
    • Beckman, Robert A.;
    • Demetri, George D.
    Publication type:
    Article
    11
    12
    13

    Remote Home Monitoring of Patients with Cancer During the COVID-19 Pandemic.

    Published in:
    Oncology Issues, 2022, v. 37, n. 3, p. 20, doi. 10.1080/10463356.2022.2055427
    By:
    • Steimer, Mary;
    • Leabo, Jessica;
    • Wang, Hongkun;
    • Heyer, David;
    • Bowles, Nancy;
    • Matthews, Laura;
    • Cannon, Timothy L.;
    • Cuevo, Raymund;
    • Ershler, William B.;
    • Shafer, Danielle;
    • Jang, Sekwon;
    • Pennisi, Angela;
    • Al-Hussain, Amjaad;
    • Farrell, Kirby;
    • Deeken, John F.
    Publication type:
    Article
    14
    15

    Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.

    Published in:
    Cells (2073-4409), 2019, v. 8, n. 11, p. 1327, doi. 10.3390/cells8111327
    By:
    • Palechor-Ceron, Nancy;
    • Krawczyk, Ewa;
    • Dakic, Aleksandra;
    • Simic, Vera;
    • Yuan, Hang;
    • Blancato, Jan;
    • Wang, Weisheng;
    • Hubbard, Fleesie;
    • Zheng, Yun-Ling;
    • Dan, Hancai;
    • Strome, Scott;
    • Cullen, Kevin;
    • Davidson, Bruce;
    • Deeken, John F.;
    • Choudhury, Sujata;
    • Ahn, Peter H.;
    • Agarwal, Seema;
    • Zhou, Xuexun;
    • Schlegel, Richard;
    • Furth, Priscilla A.
    Publication type:
    Article
    16

    A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061.

    Published in:
    Infectious Agents & Cancer, 2012, v. 7, n. Suppl 1, p. 1, doi. 10.1186/1750-9378-7-S1-O15
    By:
    • Deeken, John F.;
    • Rudek, Michelle A.;
    • Moore, Page C.;
    • Aboulafia, David;
    • Sullivan, Ryan;
    • Gerecitano, John;
    • Cianfrocca, Mary;
    • Henry, David;
    • Ratner, Lee;
    • Dezube, Bruce;
    • Mosby, Kimberly;
    • Tibbals, Melinda;
    • Little, Richard F.;
    • Ivy, S. P.;
    • Mitsuyasu, Ronald T.
    Publication type:
    Article